Even though BRCA1 breast carcinomas harbor in the majority of the cases a TN phenotype (85% of the cases), luminal (ER-positive) or HER2-positive phenotypes also have been reported [22, 28]. This evidence concerns the gene BRCA1 and breast carcinoma.